This inventor holds 2 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: Neuroscienze Pharmaness S.c.a.r.l.. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Giovanni Loriga: Innovator in Pharmaceutical Compounds
Introduction
Giovanni Loriga is a notable inventor based in Sassari, Italy. He has made significant contributions to the field of pharmaceutical compounds, particularly in the development of diazabicyclic derivatives. With a total of 2 patents, his work focuses on compounds that have potential therapeutic applications.
Latest Patents
Loriga's latest patents include innovative compounds such as substituted 3,8-diazabicyclo[3.2.1]octane compounds. These compounds exhibit affinity for opioidergic receptors, specifically targeting delta opioidergic receptors, and demonstrate both central and peripheral activity. Another notable patent involves nonane and decane diazabicyclic derivatives that feature homopiperazine as the main ring. These derivatives also show affinity for various opioidergic receptors, including μ, δ, and κ receptors, along with their subclasses.
Career Highlights
Giovanni Loriga is currently associated with Neuroscienze Pharmaness S.c.a.r.l., where he continues to advance his research in pharmaceutical innovations. His work is characterized by a commitment to developing compounds that can potentially improve therapeutic outcomes for patients.
Collaborations
Throughout his career, Loriga has collaborated with esteemed colleagues such as Luca Pani and Paolo Lazzari. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Giovanni Loriga stands out as an influential inventor in the pharmaceutical industry, with a focus on innovative compounds that target critical receptors in the human body. His contributions are paving the way for future advancements in therapeutic applications.